Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingdi Zhao

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 19, 2022
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete responseYu Zhou, Baozhen Ma, Tiepeng Li, et al.
Immunotherapy|June 28, 2017
Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimenYonghao Yang, Hongwei Lin, Lingdi Zhao, et al.
Immunotherapy|August 29, 2018
Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature reviewLingdi Zhao, Yonghao Yang, Wei Li, et al.
Immunotherapy|August 31, 2022
Complete remission of ovarian clear cell carcinoma achieved after pseudoprogression during PD-1 inhibitor therapyBaozhen Ma, Lingdi Zhao, Yong Zhang, et al.
Cancer Science|May 17, 2022
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1Lihua Dong, Jingjing Huang, Xue Gao, et al.
Journal of Translational Medicine|May 22, 2026
METTL3-dependent m<sup>6</sup>A-modified circ_0026652 facilitates immune evasion of diffuse large B-cell lymphoma cells by inhibiting CD8<sup>+</sup> T-cell responsesXue Gao, Danyang Wang, Jianwei Du, et al.
Frontiers in Oncology|June 15, 2026
Solitary intracranial metastasis as the sole relapse site in gastric cancer patients after neoadjuvant therapy and surgery: a case series of 12 patients and clinical implicationsWeijie Zhao, Guanglong Chen, Yijie Ma, et al.
Photodiagnosis and Photodynamic Therapy|August 17, 2024
Tongue squamous cell carcinoma treated by 5-aminolevulinic acid administrated through Microdrop methodYong Zhang, Anqi Lyu, Fang Zhang, et al.
Oncotargets and Therapy|October 23, 2015
Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trialsLingdi Zhao, Wei Li, Huiying Zhang, et al.
BMC Gastroenterology|October 24, 2021
Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literatureYong Zhang, Fang Zhang, Lingdi Zhao, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 19, 2022
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete responseYu Zhou, Baozhen Ma, Tiepeng Li, et al.
Immunotherapy|June 28, 2017
Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimenYonghao Yang, Hongwei Lin, Lingdi Zhao, et al.
Immunotherapy|August 29, 2018
Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature reviewLingdi Zhao, Yonghao Yang, Wei Li, et al.
Immunotherapy|August 31, 2022
Complete remission of ovarian clear cell carcinoma achieved after pseudoprogression during PD-1 inhibitor therapyBaozhen Ma, Lingdi Zhao, Yong Zhang, et al.
Cancer Science|May 17, 2022
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1Lihua Dong, Jingjing Huang, Xue Gao, et al.
Journal of Translational Medicine|May 22, 2026
METTL3-dependent m<sup>6</sup>A-modified circ_0026652 facilitates immune evasion of diffuse large B-cell lymphoma cells by inhibiting CD8<sup>+</sup> T-cell responsesXue Gao, Danyang Wang, Jianwei Du, et al.
Frontiers in Oncology|June 15, 2026
Solitary intracranial metastasis as the sole relapse site in gastric cancer patients after neoadjuvant therapy and surgery: a case series of 12 patients and clinical implicationsWeijie Zhao, Guanglong Chen, Yijie Ma, et al.
Photodiagnosis and Photodynamic Therapy|August 17, 2024
Tongue squamous cell carcinoma treated by 5-aminolevulinic acid administrated through Microdrop methodYong Zhang, Anqi Lyu, Fang Zhang, et al.
Oncotargets and Therapy|October 23, 2015
Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trialsLingdi Zhao, Wei Li, Huiying Zhang, et al.
BMC Gastroenterology|October 24, 2021
Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literatureYong Zhang, Fang Zhang, Lingdi Zhao, et al.
Pageof 6